FDARegulatoryvia Quantisnow

FDA Approval for SKYCLARYS issued to REATA PHARMACEUTICALS INC

ByQuantisnow·Feb 28, 2023 · 17:14:09 ET·Wall Street's wire, on your screen.

Stocks in this Quantisnow insightHealth Care

RETANASDAQReata Pharmaceuticals Inc.
Alert me

Ask Ellis, your finance intern, about this story

Keep researching RETA

FDA approval processA new drug needs an IND to start human trials and an approved NDA or BLA to be sold. Learn each FDA step, review timelines, expedited programs and what a CRL means.

Quantisnow market dataNASDAQ

RETA

Reata Pharmaceuticals Inc.

Market cap
30-day
Sector: Health Care
Industry: Biotechnology: Pharmaceutical Preparations
Listed since: 2016

Get push alerts for RETA

Follow RETA and get a push notification the moment its next story breaks.

Full RETA profile on Quantisnow

Delivered by Quantisnow

Get the next RETA story 35ms after it publishes

Quantisnow reads SEC filings, FDA decisions, analyst ratings, insider trades and press releases straight off the wire and alerts you on the tickers you follow, so you read it before the market prices it in.

Push to your phoneQuantisnow app for iOS and Android
Email alertHeadline, tickers and the source link
Live feedStreams in as the wire publishes

Quantisnow Free vs Plus
Feature	Free	Plus
Delivery	On a delay	Real time, ~35ms
Followed tickers	Up to 5	Up to 250
Push + email alerts	Daily limit	Every story
Price	$0	$69/mo

Original source Picked up and delivered by Quantisnow in real time